DIN 02248966 — FABRAZYME 35 MG
FABRAZYME is a powder for solution of Agalsidase beta marketed by SANOFI-AVENTIS CANADA INC. The full Agalsidase beta monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02248966
- Brand name
- FABRAZYME
- Active ingredient
- Agalsidase beta
- Strength
- 35 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Enzyme replacement therapy (alpha-galactosidase A)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Agalsidase beta products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02248965 | FABRAZYME | 5 MG | POWDER FOR SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |